Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or...
For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in...
In this Episode of Allstarcharts Weekly, Steve and I talk about the recent strength in Gold, even in the face of a Dollar that has yet to start falling. After Thursday and Friday's turn around, I think it's finally time for the Dollar to weaken. The...
We've wanted to be erring on the long side of stocks if the major Indexes are above their 2018 highs. That has been the strategy for the second half of 2019. But what if we're not above those highs? Then what?
I've made no secret about it. I've been bullish on Twitter -- the business -- since I first discovered the power of the platform in 2009. To say that Twitter has profoundly changed my life for the better would be a vast understatement. Sure, the...
